Tien Liang BioTech Co., Ltd. (4127.TWO) Key Statistics
$36.65TWO: 4127.TWOMarket Cap $1.91B
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Tien Liang BioTech Co., Ltd. (4127.TWO), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
27.40
P/B ratioShare price divided by book value per share.
3.67
P/S ratioMarket value divided by annual revenue.
2.93
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
58.29%
Operating marginRevenue left after operating costs.
5.31%
Net marginRevenue left after every cost, including tax and interest.
10.62%
Return on equityProfit as a percentage of shareholders’ equity.
14.25%
Return on assetsProfit as a percentage of total assets.
0.31%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
0.45
Quick ratioThe same, excluding inventory.
0.35
Debt to equityTotal borrowings against shareholders’ equity.
1.15
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$1.52
Book value per shareShareholders’ equity divided by shares outstanding.
$11.35
Shares outstandingShares currently issued.
45,760,000
Market capitalisationShare price times shares outstanding.
$1.91B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
88
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Payout ratioShare of profit paid out as dividends.
Tien Liang BioTech Co., Ltd. (4127.TWO) trades on a price-to-earnings ratio of 27.40.
What is Tien Liang BioTech Co., Ltd.'s return on equity?
Tien Liang BioTech Co., Ltd. (4127.TWO) reports a return on equity of 14.25%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Tien Liang BioTech Co., Ltd. carry?
Tien Liang BioTech Co., Ltd. (4127.TWO) has a debt-to-equity ratio of 1.15, which compares total borrowings with shareholders' equity.
What is Tien Liang BioTech Co., Ltd.'s profit margin?
Tien Liang BioTech Co., Ltd. (4127.TWO) keeps 10.62% of revenue as net profit after every cost, including tax and interest.